Etomidate use in severe sepsis and septic shock patients does not contribute to mortality

Internal and Emergency Medicine

Volumn 6, Issue 3, 2011, Pages 253-257

  Ehrman, Robert ^a   Wira, Charles ^a   Lomax, Afsaneh ^b   Hayward, Alison ^b   Marcelin, Jean ^b   Ellis, Thomas ^b   Przyklenk, Karin ^c   Volturo, Gregory ^b   Mullen, Marie ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Etomidate; Intubation; Mortality; Sepsis

Indexed keywords

ETOMIDATE;

FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; REVIEW; SEPSIS; SEPTIC SHOCK;

ETOMIDATE; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC;

EID: 79956316384     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-011-0553-3     Document Type: Review

References (14)

1. Jackson WL Jr (2005) Should we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?: a critical appraisal. Chest 127(3): 1031-1038.
2. Schenarts CL, Burton JH, Riker RR (2001) Adrenocortical dysfunction following etomidate induction in emergency department patients. Acad Emerg Med 8(1): 1-7.
3. Zed PJ, Abu-Laban RB, Harrison DW (2006) Intubating conditions and hemodynamic effects of etomidate for rapid sequence intubation in the emergency department: an observational cohort study. Acad Emerg Med 13(4): 378-383.
4. Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7): 862-871.
5. den Brinker M, Joosten KF, Liem O et al (2005) Adrenal insufficiency in meningococcal sepsis: bioavailable cortisol levels and impact of interleukin-6 levels and intubation with etomidate on adrenal function and mortality. J Clin Endocrinol Metab 90(9): 5110-5117.
6. Malerba G, Romano-Girard F, Cravoisy A et al (2005) Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation. Intensive Care Med 31(3): 388-392.
7. Mohammad Z, Afessa B, Finkielman JD (2006) The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate. Crit Care 10(4): R105.
8. Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358(2): 111-124.
9. Annane D, Maxime V, Ibrahim F et al (2006) Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 174(12): 1319-1326.
10. Ray DC, McKeown DW (2007) Effect of induction agent on vasopressor and steroid use, and outcome in patients with septic shock. Crit Care 11(3): R56.
11. Jabre P, Combes X, Lapostolle F et al (2009) Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial. Lancet 374: 293-300.
12. Dmello D, Taylor S, O'Brien J, Matuschak GM (2010) Outcomes of Etomidate in Severe Sepsis and Septic Shock. Chest [Epub ahead of print].
13. Brun-Buisson C, Doyon F, Carlet J et al (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A Multicenter Prospective Study in Intensive Care Units. JAMA 274(12): 968-974.
14. Annane D, Aegerter P, Jars-Guincestre M et al (2003) Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med 168(2): 165-172.